Pages with the fewest revisions
Showing below up to 50 results in range #1,001 to #1,050.
- B18. Pelvic organ prolapse; therapy (1 revision)
- 9. Morbidity and mortality of malignant diseases (1 revision)
- 25. General pathophysiology and classification of systemic hypertension – age and blood pressure (1 revision)
- 15. Imaging of the liver and the hepatobiliary system. Imaging techniques, indications, information content. (1 revision)
- 53. Drug treatment of neurodegenerative disorders (1 revision)
- B21. Threatened preterm delivery; pathomechanism, management (1 revision)
- 26. Causes, types and pathomechanisms of shock. Disseminated intravascular coagulation (DIC) (1 revision)
- 16. Epidemiological indicators I: indicators of disease frequency and population impact of a disease (1 revision)
- 55. Disorders of the hypothalamo-pituitary system. Pituitary insufficiency (1 revision)
- 38. Infectious diseases of the CNS (1 revision)
- Distal radius fracture (1 revision)
- A13. The criteria and the potential complications of IUD usage (1 revision)
- 26. Urothelial carcinoma of the bladder (1 revision)
- 17. Acute and chronic pancreatitis. Tumours of the pancreas (1 revision)
- 57. Adjuvant analgesics. Centrally-acting muscle relaxants (1 revision)
- 39. Radioisotope diagnostics of pulmonary embolism (perfusion and inhalation). Radioisotope methods in pulmonary malignancies. (1 revision)
- Tumours of the external ear (1 revision)
- B29. Vaginal delivery after prior uterine surgery (1 revision)
- 27. Laboratory diagnostics of the striated muscle diseases. (1 revision)
- 59. Diseases of the upper airways (1 revision)
- 17. Nucleotide synthesis and degradation (1 revision)
- Urine culture (1 revision)
- Organ transplantation and immunosuppression (1 revision)
- Facial nerve palsy (1 revision)
- B34. Perianal abscesses and fistulae. Surgical management of hemorrhoids. (1 revision)
- A20. The most frequent pyogenous infections (1 revision)
- 6. Epidemiology and prevention of cerebrovascular diseases (1 revision)
- 18. Genes and chromosomes (1 revision)
- 40. Glial central nervous system tumours (1 revision)
- 28. Indolent B cell lymphomas (FL, CLL, MCL, MZL) (+ introduction to haematological malignancies) (1 revision)
- Vestibular schwannoma (1 revision)
- B43. Thoracic empyema and infective thoracic disorders (1 revision)
- 60. Mesothelioma (1 revision)
- 41. Nonglial central nervous system tumors (1 revision)
- 29. Consequences of hypertension (1 revision)
- B54. Surgery for chronic pancreatitis. (1 revision)
- A6. Postmenopausal bleeding (1 revision)
- 19. The placodes, the neural crest and their derivatives. Development of the peripheral nervous system (1 revision)
- 10. Genetic disorders of hemoglobin (1 revision)
- Pernicious anaemia (1 revision)
- Hallux valgus (1 revision)
- B8. Scapula and clavicle fractures. Dislocation of the AC, SC and shoulder joints. (1 revision)
- A9. Cystourethroscopy: Requirements, technique, and indications (1 revision)
- 107. Environmental monitoring and protection. Health effects of global environmental issues (1 revision)
- 44. Brain perfusion examinations in nuclear medicine (indications, radiopharmaceuticals, imaging). (1 revision)
- 3. Radiation physics (1 revision)
- Hereditary deafness (1 revision)
- Benign tumours of the oral cavity (1 revision)
- 68. Parathyroid abnormalities (1 revision)
- 20. DNA repair (1 revision)